These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34570593)

  • 1. Letter by Varricchi et al Regarding Article, "Role of IgE-FcεR1 in Pathological Cardiac Remodeling and Dysfunction".
    Varricchi G; Rengo G; Galli SJ
    Circulation; 2021 Sep; 144(13):e214-e215. PubMed ID: 34570593
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of IgE-FcεR1 in Pathological Cardiac Remodeling and Dysfunction.
    Zhao H; Yang H; Geng C; Chen Y; Pang J; Shu T; Zhao M; Tang Y; Li Z; Li B; Hou C; Song X; Wu A; Guo X; Chen S; Liu B; Yan C; Wang J
    Circulation; 2021 Mar; 143(10):1014-1030. PubMed ID: 33305586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response by Zhao et al to Letter Regarding Article, "Role of IgE-FcεRI in Pathological Cardiac Remodeling and Dysfunction".
    Zhao H; Geng C; Yan C; Wang J
    Circulation; 2021 Sep; 144(13):e216-e217. PubMed ID: 34570594
    [No Abstract]   [Full Text] [Related]  

  • 4. IgE and TGF-β Signaling: From Immune to Cardiac Remodeling.
    Cao H; Xiao C; He Z; Huang H; Tang H
    J Inflamm Res; 2021; 14():5523-5526. PubMed ID: 34737601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter by Wang et al Regarding Article, "A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction".
    Wang D; Yang X; Yu X
    Circulation; 2020 Jul; 142(3):e34-e35. PubMed ID: 32687447
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated IgE promotes cardiac fibrosis by suppressing miR-486a-5p.
    Zhao H; Yang H; Geng C; Chen Y; Tang Y; Li Z; Pang J; Shu T; Nie Y; Liu Y; Jia K; Wang J
    Theranostics; 2021; 11(15):7600-7615. PubMed ID: 34158869
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter by Wang et al Regarding Article, "Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking".
    Wang W; Li T; Yao HC
    Circulation; 2019 Nov; 140(19):e762-e763. PubMed ID: 31682524
    [No Abstract]   [Full Text] [Related]  

  • 8. Response by Lewandowski et al to Letter Regarding Article, "Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking".
    Lewandowski ED; Goldenberg JR; Carley AN; Schulze PC
    Circulation; 2019 Nov; 140(19):e764-e765. PubMed ID: 31682528
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter regarding article by Thambo et al, "Detrimental ventricular remodeling in patients with congenital complete heart block and chronic right ventricular apical pacing".
    Abdul-Khaliq H; Abd El Rahman MY; Hui W
    Circulation; 2005 Jul; 112(4):e70; author reply e70. PubMed ID: 16043654
    [No Abstract]   [Full Text] [Related]  

  • 10. Response by Chen and Yan to Letter Regarding Article, "A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction".
    Chen S; Yan C
    Circulation; 2020 Jul; 142(3):e36-e37. PubMed ID: 32687445
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter by Mehmood Regarding Article, "Cardiac Remodeling During Pregnancy With Metabolic Syndrome: Prologue of Pathological Remodeling".
    Mehmood M
    Circulation; 2021 Jul; 144(4):e68. PubMed ID: 34310162
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Letter Regarding Article, "Cardiac Remodeling During Pregnancy With Metabolic Syndrome: Prologue of Pathological Remodeling".
    Yang Y; Houser SR
    Circulation; 2021 Jul; 144(4):e69. PubMed ID: 34310164
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Sanchis-Gomar et al Regarding Article, "Cardiac Remodeling in Response to 1 Year of Intensive Endurance Training".
    Sanchis-Gomar F; Joyner MJ; Lucia A
    Circulation; 2015 Sep; 132(11):e146. PubMed ID: 26371240
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter by Wang et al Regarding Article, "Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".
    Wang D; Yang X; Zhong H
    Circulation; 2019 Jun; 139(24):e1033-e1034. PubMed ID: 31180754
    [No Abstract]   [Full Text] [Related]  

  • 15. Response by Bansal et al to Letter Regarding Article, "Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".
    Bansal SS; Ismahil MA; Goel M; Zhou G; Rokosh G; Hamid T; Prabhu SD
    Circulation; 2019 Jun; 139(24):e1035-e1036. PubMed ID: 31180753
    [No Abstract]   [Full Text] [Related]  

  • 16. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.
    Wang J; Cheng X; Xiang MX; Alanne-Kinnunen M; Wang JA; Chen H; He A; Sun X; Lin Y; Tang TT; Tu X; Sjöberg S; Sukhova GK; Liao YH; Conrad DH; Yu L; Kawakami T; Kovanen PT; Libby P; Shi GP
    J Clin Invest; 2011 Sep; 121(9):3564-77. PubMed ID: 21821913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter by Banker et al regarding article, "cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial".
    Banker J; Rosenheck S; Gotsman I
    Circulation; 2013 Oct; 128(14):e216. PubMed ID: 24081958
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter by Dai et al regarding article, "cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial".
    Dai H; Guang X; Xiao Z
    Circulation; 2013 Oct; 128(14):e217. PubMed ID: 24081959
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter by Reil et al regarding article, "Differential cardiac remodeling in preload versus afterload".
    Reil JC; Hohl M; Böhm M
    Circulation; 2011 Apr; 123(16):e420; author reply e421. PubMed ID: 21518988
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter by Moody et al regarding article "Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction".
    Moody WE; Edwards NC; Townend JN
    Circulation; 2012 Jul; 126(5):e62; author reply e64-5. PubMed ID: 22850367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.